Optimization of bipyridinyl pyrazole scaffolds via design, synthesis and screening of a new series of ROS1 kinase-modulating compounds
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Al-Sanea, M.M. | - |
dc.contributor.author | Park, K.B.S. | - |
dc.contributor.author | Abdelazem, K.A.Z. | - |
dc.contributor.author | Selim, K.B. | - |
dc.contributor.author | Yoo, K.H. | - |
dc.contributor.author | Sim, T. | - |
dc.contributor.author | Tae, J.S. | - |
dc.contributor.author | Lee, S.H. | - |
dc.date.accessioned | 2021-09-04T23:59:48Z | - |
dc.date.available | 2021-09-04T23:59:48Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0253-2964 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95943 | - |
dc.description.abstract | A series of rationally designed ROS1 tyrosine kinase inhibitors 6a-9b with bipyridinyl pyrazole scaffold was synthesized and screened. The scaffold itself has showed an exclusive selectivity profile over ROS1 closely related kinases,ALKand c-Met. The aim of this study was to further explore the structure-activity relationships (SAR) of the bipyridinyl pyrazole core structure, and to improve its ROS1 inhibitory potency. The rational of this study was to explore the nature of the proposed binding site for the pyrazoleNHsubstituents. Careful selections of pyrazoleNHsubstituent groups along with their regioisomers were considered. The compounds exhibited high degree of potency, IC50 values of 21-159 nM. A detailed SAR of bipyridinyl pyrazole scaffold has been finally well established and the virtual screening strategy, through molecular docking, has been performed for this type of ROS1 kinase inhibitors and the docked poses along with the activity data have gone in consistent with SAR specifications. © 2015 Korean Chemical Society , Seoul & Wiley-VCH Verlag GmbH & Co. KGaA , Weinheim. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Chemical Society | - |
dc.subject | Amino acids | - |
dc.subject | Enzyme inhibition | - |
dc.subject | Scaffolds | - |
dc.subject | Cancer | - |
dc.subject | Chromosomal alteration | - |
dc.subject | Kinase inhibitors | - |
dc.subject | Molecular docking | - |
dc.subject | Pyrazoles | - |
dc.subject | Structure-activity relationships | - |
dc.subject | Tyrosine kinase inhibitor | - |
dc.subject | Virtual screening strategies | - |
dc.subject | Enzymes | - |
dc.title | Optimization of bipyridinyl pyrazole scaffolds via design, synthesis and screening of a new series of ROS1 kinase-modulating compounds | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sim, T. | - |
dc.identifier.doi | 10.1002/bkcs.10077 | - |
dc.identifier.scopusid | 2-s2.0-84921924556 | - |
dc.identifier.bibliographicCitation | Bulletin of the Korean Chemical Society, v.36, no.1, pp.305 - 311 | - |
dc.relation.isPartOf | Bulletin of the Korean Chemical Society | - |
dc.citation.title | Bulletin of the Korean Chemical Society | - |
dc.citation.volume | 36 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 305 | - |
dc.citation.endPage | 311 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001956975 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | Amino acids | - |
dc.subject.keywordPlus | Enzyme inhibition | - |
dc.subject.keywordPlus | Scaffolds | - |
dc.subject.keywordPlus | Cancer | - |
dc.subject.keywordPlus | Chromosomal alteration | - |
dc.subject.keywordPlus | Kinase inhibitors | - |
dc.subject.keywordPlus | Molecular docking | - |
dc.subject.keywordPlus | Pyrazoles | - |
dc.subject.keywordPlus | Structure-activity relationships | - |
dc.subject.keywordPlus | Tyrosine kinase inhibitor | - |
dc.subject.keywordPlus | Virtual screening strategies | - |
dc.subject.keywordPlus | Enzymes | - |
dc.subject.keywordAuthor | Bipyridinyl pyrazole | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Chromosomal alteration | - |
dc.subject.keywordAuthor | ROS1 kinase inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.